Viewing Study NCT03527251


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2025-12-31 @ 12:27 PM
Study NCT ID: NCT03527251
Status: UNKNOWN
Last Update Posted: 2018-05-30
First Post: 2018-04-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLC
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None clinical trial, phase I View
None CTLA-4 antibody View
None PD-1 antibody View
None non-small cell lung cancer View